Neuropeptides · 1984
Effects of dynorphin A (1-17), dynorphin A (1-13) and D-ala2-D-leu5-enkephalin on the excitability of pyramidal cells in CA1 and CA2 of the rat hippocampus in vitro.
Сравнительное исследованиеСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Vidal C, Maier R, Zieglgänsberger W
Аннотация
The effects of D-ala2-D-leu5-enkephalin (DADL), dynorphin (DYN) A (1-17), and DYN A (1-13) on the excitability of hippocampal (HC) pyramidal cells in CA1 and CA2 were compared in an in vitro preparation of the rat. DADL and DYN A (1-13) increased the size of the population spike (PS) evoked in CA1 and CA2 by stimulation of the stratum radiatum. Paired-pulse stimulation showed that both peptides decreased the inhibition produced by the conditioning stimulus. These effects were naloxone-reversible. DYN A (1-17) decreased the PS in CA2 and increased the inhibition evoked by the conditioning stimulus. When applied in the same concentration-range, the depressant effects of DYN A (1-17) were more pronounced in CA1 than in CA2 and not naloxone-reversible. DYN A (1-17) reduced the excitatory effects of DADL. Low concentrations of DYN A (1-17) (0.1 nM) produced, like DYN A (1-13) and DADL, an increase in the PS in CA1 in the majority of tests. The present data suggest that DYN A (1-17) shows the excitatory action of other opioids HC pyramidal cells only at low concentration.